Mallika Alvala - Search Results

Year	Number of Results
2010	1
2011	3
2012	7
2013	3
2014	7
2015	4
2016	3
2017	5
2018	2
2019	10
2020	8
2021	5
2022	1
2023	1
2024	3

1

Targeting Integrase Enzyme: A Therapeutic Approach to Combat HIV Resistance.

Komal D, Khushboo J, Aaftaab S, Lakshmi S, Mallika A. Komal D, et al. Among authors: mallika a. Mini Rev Med Chem. 2020;20(3):219-238. doi: 10.2174/1389557519666191015124932. Mini Rev Med Chem. 2020. PMID: 31613727 Review.

2

Mycobacterium tuberculosis chorismate mutase: A potential target for TB.

Khanapur M, Alvala M, Prabhakar M, Shiva Kumar K, Edwin RK, Sri Saranya PS, Patel RK, Bulusu G, Misra P, Pal M. Khanapur M, et al. Among authors: alvala m. Bioorg Med Chem. 2017 Mar 15;25(6):1725-1736. doi: 10.1016/j.bmc.2017.02.001. Epub 2017 Feb 4. Bioorg Med Chem. 2017. PMID: 28202315 Review.

3

Novel trisaccharide based phospholipids as immunomodulators.

Bonam SR, Bhunia D, Muller S, Nerella SG, Alvala M, Halmuthur Mahabalarao SK. Bonam SR, et al. Among authors: alvala m. Int Immunopharmacol. 2019 Sep;74:105684. doi: 10.1016/j.intimp.2019.105684. Epub 2019 Jun 12. Int Immunopharmacol. 2019. PMID: 31200340

4

Antimicrobial Peptides: A Promising Therapeutic Strategy in Tackling Antimicrobial Resistance.

Nuti R, Goud NS, Saraswati AP, Alvala R, Alvala M. Nuti R, et al. Among authors: alvala m. Curr Med Chem. 2017;24(38):4303-4314. doi: 10.2174/0929867324666170815102441. Curr Med Chem. 2017. PMID: 28814242 Review.

5

Human Galectin-1 and Its Inhibitors: Privileged Target for Cancer and HIV.

Goud NS, Soukya PSL, Ghouse M, Komal D, Alvala R, Alvala M. Goud NS, et al. Among authors: alvala m. Mini Rev Med Chem. 2019;19(16):1369-1378. doi: 10.2174/1389557519666190304120821. Mini Rev Med Chem. 2019. PMID: 30834831 Review.

6

Non-carbohydrate strategies to inhibit lectin proteins with special emphasis on galectins.

Sethi A, Sanam S, Alvala M. Sethi A, et al. Among authors: alvala m. Eur J Med Chem. 2021 Oct 15;222:113561. doi: 10.1016/j.ejmech.2021.113561. Epub 2021 Jun 2. Eur J Med Chem. 2021. PMID: 34146913 Review.

7

An updated patent review of galectin-1 and galectin-3 inhibitors and their potential therapeutic applications (2016-present).

Sethi A, Sanam S, Alvala R, Alvala M. Sethi A, et al. Among authors: alvala m. Expert Opin Ther Pat. 2021 Aug;31(8):709-721. doi: 10.1080/13543776.2021.1903430. Epub 2021 May 20. Expert Opin Ther Pat. 2021. PMID: 33749494 Review.

8

Synthesis of Substituted Cinnamido Linked Quinazolinone Congeners as Potential Anticancer Agents via Mitochondrial Dependent Intrinsic Apoptotic Pathway.

Manasa KL, Saifi MA, Tangella Y, Godugu C, Alvala M. Manasa KL, et al. Among authors: alvala m. Anticancer Agents Med Chem. 2019;19(16):1935-1948. doi: 10.2174/1871520619666190906162537. Anticancer Agents Med Chem. 2019. PMID: 31490766 Review.

9

MEMES: Machine learning framework for Enhanced MolEcular Screening.

Mehta S, Laghuvarapu S, Pathak Y, Sethi A, Alvala M, Priyakumar UD. Mehta S, et al. Among authors: alvala m. Chem Sci. 2021 Jul 26;12(35):11710-11721. doi: 10.1039/d1sc02783b. eCollection 2021 Sep 15. Chem Sci. 2021. PMID: 34659706 Free PMC article.

10

Can targeting SIRT-1 to treat type 2 diabetes be a good strategy? A review.

Pulla VK, Battu MB, Alvala M, Sriram D, Yogeeswari P. Pulla VK, et al. Among authors: alvala m. Expert Opin Ther Targets. 2012 Aug;16(8):819-32. doi: 10.1517/14728222.2012.703656. Epub 2012 Jul 5. Expert Opin Ther Targets. 2012. PMID: 22762724 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

59 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

59 results

Results by year